André Richters

André Richters is a Senior Scientist at Plexium, focusing on redirecting E3 ligases with small molecules to degrade tumor specific targets. Previously, André held positions at MIT Koch Institute for Integrative Cancer Research and Broad Institute of MIT and Harvard, where André worked on targeted degradation studies, PROTACs, LYTACs, transcriptional regulation, structure-based drug design, and more. André also conducted research at TU Dortmund University and Max-Planck Institute for Molecular Physiology, specializing in kinase inhibitors and molecular probes in chemical biology.